Status:
COMPLETED
Patient Education in NorthTrondelag Hospital Trust
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Helse Nord-Trøndelag HF
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The purpose of this randomised open study is to examine the effect of self-management program for diabetes patients.
Detailed Description
The primary aim in this study is HbA1c in addition to secondary aims like quality of life and coping.
Eligibility Criteria
Inclusion
- Diagnosed with ICPC-2, code T89 - diabetes dependent on insulin and T90 diabetes not dependent on insulin
Exclusion
- Diagnosed with ICPC-2, code T89 - diabetes mellitus juvenile and diabetes I
- Attended self-management program previous 12 months
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT00326222
Start Date
May 1 2006
End Date
November 1 2008
Last Update
July 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nord-Trondelag Hospital Trust
Levanger, Nord-Trondelag, Norway, 7600